Community-Pharmacy based Trials for Drug Dose Adjustment in which Pharmacists Evaluate Renal Function Article Swipe
Rika Eto
,
Koichiro Amamoto
,
Yasuji Ueshima
,
Kentaro Yamaguchi
,
Takeshi Doi
,
Ken Shimosaka
,
Mie Honma
,
Ayako Kawamura
,
Kazuhide Inoue
,
Akinobu Miyazaki
,
Mikiro Nakashima
,
Hitoshi Saikusa
,
Nobuhiro Masuda
,
Yoshiaki Kamachi
,
Hiroyuki Tashiro
,
Harumi Yamada
,
Yoko Soh
,
Kiyomi Hoshiko
,
Sumío Hirata
,
Choichiro Miyazaki
·
YOU?
·
· 2015
· Open Access
·
· DOI: https://doi.org/10.5649/jjphcs.41.732
YOU?
·
· 2015
· Open Access
·
· DOI: https://doi.org/10.5649/jjphcs.41.732
In patients with chronic kidney disease (CKD), cautious drug dose adjustment is required as adverse effects including drug-induced acute kidney injury or drug intoxication may occur when an inappropriate dose of medicine is administered. We herein performed family-pharmacy based trials for drug dose adjustment in which pharmacists evaluate renal function of the patients using a hearing survey. In our group it was revealed that 50.3% of the outpatients have impaired renal function as their average eGFR was below 60 mL/min / 1.73 m2, and suggested that we need to confirm the degree of their renal insufficiency in the dispensing work. The ratio of inquiry for prescribed medicine from pharmacists to doctors was 3.3%, and 53.2% of these inquired prescriptions was readjusted, indicating this inquiry system potentially contributed to appropriate medication. The role of family pharmacies is considered to be important in the inspection of prescribed drugs for the patients with impaired renal function who visit multiple clinics, and is expected to be the last bastion as the inspector for safe administration of drugs.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.5649/jjphcs.41.732
- https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdf
- OA Status
- bronze
- Cited By
- 7
- References
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2528374139
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2528374139Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5649/jjphcs.41.732Digital Object Identifier
- Title
-
Community-Pharmacy based Trials for Drug Dose Adjustment in which Pharmacists Evaluate Renal FunctionWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2015Year of publication
- Publication date
-
2015-01-01Full publication date if available
- Authors
-
Rika Eto, Koichiro Amamoto, Yasuji Ueshima, Kentaro Yamaguchi, Takeshi Doi, Ken Shimosaka, Mie Honma, Ayako Kawamura, Kazuhide Inoue, Akinobu Miyazaki, Mikiro Nakashima, Hitoshi Saikusa, Nobuhiro Masuda, Yoshiaki Kamachi, Hiroyuki Tashiro, Harumi Yamada, Yoko Soh, Kiyomi Hoshiko, Sumío Hirata, Choichiro MiyazakiList of authors in order
- Landing page
-
https://doi.org/10.5649/jjphcs.41.732Publisher landing page
- PDF URL
-
https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdfDirect OA link when available
- Concepts
-
Medicine, Pharmacy, Drug, Renal function, Medical prescription, Kidney disease, Intensive care medicine, Clinical trial, Impaired renal function, Adverse effect, Clinical pharmacy, Internal medicine, Emergency medicine, Pharmacology, Family medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2023: 1, 2020: 1, 2018: 2, 2017: 1Per-year citation counts (last 5 years)
- References (count)
-
1Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2528374139 |
|---|---|
| doi | https://doi.org/10.5649/jjphcs.41.732 |
| ids.doi | https://doi.org/10.5649/jjphcs.41.732 |
| ids.mag | 2528374139 |
| ids.openalex | https://openalex.org/W2528374139 |
| fwci | 1.48781065 |
| type | article |
| title | Community-Pharmacy based Trials for Drug Dose Adjustment in which Pharmacists Evaluate Renal Function |
| biblio.issue | 10 |
| biblio.volume | 41 |
| biblio.last_page | 739 |
| biblio.first_page | 732 |
| topics[0].id | https://openalex.org/T13970 |
| topics[0].field.id | https://openalex.org/fields/30 |
| topics[0].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[0].score | 0.9980000257492065 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3004 |
| topics[0].subfield.display_name | Pharmacology |
| topics[0].display_name | Pharmacy and Medical Practices |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9164915084838867 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C104863432 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7864167094230652 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q614304 |
| concepts[1].display_name | Pharmacy |
| concepts[2].id | https://openalex.org/C2780035454 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7085837125778198 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[2].display_name | Drug |
| concepts[3].id | https://openalex.org/C159641895 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6783922910690308 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q108377937 |
| concepts[3].display_name | Renal function |
| concepts[4].id | https://openalex.org/C2426938 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6767273545265198 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[4].display_name | Medical prescription |
| concepts[5].id | https://openalex.org/C2778653478 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5166640281677246 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1054718 |
| concepts[5].display_name | Kidney disease |
| concepts[6].id | https://openalex.org/C177713679 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5016062259674072 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[6].display_name | Intensive care medicine |
| concepts[7].id | https://openalex.org/C535046627 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4722197353839874 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[7].display_name | Clinical trial |
| concepts[8].id | https://openalex.org/C2908822073 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4687421917915344 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q108377937 |
| concepts[8].display_name | Impaired renal function |
| concepts[9].id | https://openalex.org/C197934379 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4657704532146454 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[9].display_name | Adverse effect |
| concepts[10].id | https://openalex.org/C10446079 |
| concepts[10].level | 3 |
| concepts[10].score | 0.44000205397605896 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q155491 |
| concepts[10].display_name | Clinical pharmacy |
| concepts[11].id | https://openalex.org/C126322002 |
| concepts[11].level | 1 |
| concepts[11].score | 0.4316129684448242 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[11].display_name | Internal medicine |
| concepts[12].id | https://openalex.org/C194828623 |
| concepts[12].level | 1 |
| concepts[12].score | 0.37179458141326904 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2861470 |
| concepts[12].display_name | Emergency medicine |
| concepts[13].id | https://openalex.org/C98274493 |
| concepts[13].level | 1 |
| concepts[13].score | 0.3575386106967926 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[13].display_name | Pharmacology |
| concepts[14].id | https://openalex.org/C512399662 |
| concepts[14].level | 1 |
| concepts[14].score | 0.17697739601135254 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[14].display_name | Family medicine |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9164915084838867 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/pharmacy |
| keywords[1].score | 0.7864167094230652 |
| keywords[1].display_name | Pharmacy |
| keywords[2].id | https://openalex.org/keywords/drug |
| keywords[2].score | 0.7085837125778198 |
| keywords[2].display_name | Drug |
| keywords[3].id | https://openalex.org/keywords/renal-function |
| keywords[3].score | 0.6783922910690308 |
| keywords[3].display_name | Renal function |
| keywords[4].id | https://openalex.org/keywords/medical-prescription |
| keywords[4].score | 0.6767273545265198 |
| keywords[4].display_name | Medical prescription |
| keywords[5].id | https://openalex.org/keywords/kidney-disease |
| keywords[5].score | 0.5166640281677246 |
| keywords[5].display_name | Kidney disease |
| keywords[6].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[6].score | 0.5016062259674072 |
| keywords[6].display_name | Intensive care medicine |
| keywords[7].id | https://openalex.org/keywords/clinical-trial |
| keywords[7].score | 0.4722197353839874 |
| keywords[7].display_name | Clinical trial |
| keywords[8].id | https://openalex.org/keywords/impaired-renal-function |
| keywords[8].score | 0.4687421917915344 |
| keywords[8].display_name | Impaired renal function |
| keywords[9].id | https://openalex.org/keywords/adverse-effect |
| keywords[9].score | 0.4657704532146454 |
| keywords[9].display_name | Adverse effect |
| keywords[10].id | https://openalex.org/keywords/clinical-pharmacy |
| keywords[10].score | 0.44000205397605896 |
| keywords[10].display_name | Clinical pharmacy |
| keywords[11].id | https://openalex.org/keywords/internal-medicine |
| keywords[11].score | 0.4316129684448242 |
| keywords[11].display_name | Internal medicine |
| keywords[12].id | https://openalex.org/keywords/emergency-medicine |
| keywords[12].score | 0.37179458141326904 |
| keywords[12].display_name | Emergency medicine |
| keywords[13].id | https://openalex.org/keywords/pharmacology |
| keywords[13].score | 0.3575386106967926 |
| keywords[13].display_name | Pharmacology |
| keywords[14].id | https://openalex.org/keywords/family-medicine |
| keywords[14].score | 0.17697739601135254 |
| keywords[14].display_name | Family medicine |
| language | en |
| locations[0].id | doi:10.5649/jjphcs.41.732 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764699316 |
| locations[0].source.issn | 1346-342X, 1882-1499 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1346-342X |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| locations[0].source.host_organization | https://openalex.org/P4327904648 |
| locations[0].source.host_organization_name | Japanese Society of Pharmaceutical Health Care and Sciences |
| locations[0].source.host_organization_lineage | https://openalex.org/P4327904648 |
| locations[0].license | |
| locations[0].pdf_url | https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| locations[0].landing_page_url | https://doi.org/10.5649/jjphcs.41.732 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5091245127 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Rika Eto |
| authorships[0].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Rika Eto |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Nagasaki Pharmaceutical Association |
| authorships[1].author.id | https://openalex.org/A5057809830 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Koichiro Amamoto |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210091406 |
| authorships[1].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[1].affiliations[1].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[1].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[1].institutions[0].id | https://openalex.org/I96036126 |
| authorships[1].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | Kumamoto University |
| authorships[1].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[1].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[1].institutions[1].country_code | JP |
| authorships[1].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Koichiro Amamoto |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[2].author.id | https://openalex.org/A5063649728 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Yasuji Ueshima |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I96036126 |
| authorships[2].affiliations[1].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[2].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[2].institutions[0].id | https://openalex.org/I96036126 |
| authorships[2].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Kumamoto University |
| authorships[2].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[2].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[2].institutions[1].country_code | JP |
| authorships[2].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yasuji Ueshima |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[3].author.id | https://openalex.org/A5074074813 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2629-716X |
| authorships[3].author.display_name | Kentaro Yamaguchi |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I96036126 |
| authorships[3].affiliations[1].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[3].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[3].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[3].institutions[0].id | https://openalex.org/I96036126 |
| authorships[3].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | Kumamoto University |
| authorships[3].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[3].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[3].institutions[1].country_code | JP |
| authorships[3].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Kentaro Yamaguchi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[4].author.id | https://openalex.org/A5103486059 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Takeshi Doi |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[4].affiliations[0].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[4].affiliations[1].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[4].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[4].institutions[0].id | https://openalex.org/I96036126 |
| authorships[4].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Kumamoto University |
| authorships[4].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[4].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[4].institutions[1].type | healthcare |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[4].institutions[1].country_code | JP |
| authorships[4].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Takeshi Doi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[5].author.id | https://openalex.org/A5040954905 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Ken Shimosaka |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I96036126 |
| authorships[5].affiliations[1].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[5].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[5].institutions[0].id | https://openalex.org/I96036126 |
| authorships[5].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | Kumamoto University |
| authorships[5].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[5].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[5].institutions[1].country_code | JP |
| authorships[5].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ken Shimosaka |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[6].author.id | https://openalex.org/A5086274100 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Mie Honma |
| authorships[6].countries | JP |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[6].affiliations[0].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I4210091406 |
| authorships[6].affiliations[1].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[6].affiliations[2].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[6].institutions[0].id | https://openalex.org/I96036126 |
| authorships[6].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[6].institutions[0].country_code | JP |
| authorships[6].institutions[0].display_name | Kumamoto University |
| authorships[6].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[6].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[6].institutions[1].country_code | JP |
| authorships[6].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Mie Honma |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[7].author.id | https://openalex.org/A5003133683 |
| authorships[7].author.orcid | https://orcid.org/0000-0001-9218-7850 |
| authorships[7].author.display_name | Ayako Kawamura |
| authorships[7].countries | JP |
| authorships[7].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I4210091406 |
| authorships[7].affiliations[1].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[7].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[7].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[7].institutions[0].id | https://openalex.org/I96036126 |
| authorships[7].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[7].institutions[0].country_code | JP |
| authorships[7].institutions[0].display_name | Kumamoto University |
| authorships[7].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[7].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[7].institutions[1].type | healthcare |
| authorships[7].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[7].institutions[1].country_code | JP |
| authorships[7].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ayako Kawamura |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[8].author.id | https://openalex.org/A5062875895 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Kazuhide Inoue |
| authorships[8].countries | JP |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[8].affiliations[0].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[8].affiliations[1].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[8].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[8].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[8].institutions[0].id | https://openalex.org/I96036126 |
| authorships[8].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[8].institutions[0].country_code | JP |
| authorships[8].institutions[0].display_name | Kumamoto University |
| authorships[8].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[8].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[8].institutions[1].country_code | JP |
| authorships[8].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Kazuhide Inoue |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[9].author.id | https://openalex.org/A5074918706 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Akinobu Miyazaki |
| authorships[9].countries | JP |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210091406 |
| authorships[9].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I96036126 |
| authorships[9].affiliations[1].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[9].affiliations[2].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[9].institutions[0].id | https://openalex.org/I96036126 |
| authorships[9].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[9].institutions[0].country_code | JP |
| authorships[9].institutions[0].display_name | Kumamoto University |
| authorships[9].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[9].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[9].institutions[1].country_code | JP |
| authorships[9].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Akinobu Miyazaki |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[10].author.id | https://openalex.org/A5102363479 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Mikiro Nakashima |
| authorships[10].countries | JP |
| authorships[10].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I4210091406 |
| authorships[10].affiliations[1].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[10].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[10].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[10].institutions[0].id | https://openalex.org/I96036126 |
| authorships[10].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[10].institutions[0].country_code | JP |
| authorships[10].institutions[0].display_name | Kumamoto University |
| authorships[10].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[10].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[10].institutions[1].type | healthcare |
| authorships[10].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[10].institutions[1].country_code | JP |
| authorships[10].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Mikiro Nakashima |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[11].author.id | https://openalex.org/A5012446252 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Hitoshi Saikusa |
| authorships[11].countries | JP |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210091406 |
| authorships[11].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[11].affiliations[1].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[11].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[11].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[11].institutions[0].id | https://openalex.org/I96036126 |
| authorships[11].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[11].institutions[0].country_code | JP |
| authorships[11].institutions[0].display_name | Kumamoto University |
| authorships[11].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[11].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[11].institutions[1].country_code | JP |
| authorships[11].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Hitoshi Saikusa |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[12].author.id | https://openalex.org/A5043758043 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-3606-3631 |
| authorships[12].author.display_name | Nobuhiro Masuda |
| authorships[12].countries | JP |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210091406 |
| authorships[12].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[12].affiliations[1].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[12].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[12].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[12].institutions[0].id | https://openalex.org/I96036126 |
| authorships[12].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[12].institutions[0].country_code | JP |
| authorships[12].institutions[0].display_name | Kumamoto University |
| authorships[12].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[12].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[12].institutions[1].type | healthcare |
| authorships[12].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[12].institutions[1].country_code | JP |
| authorships[12].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Nobuhiro Masuda |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[13].author.id | https://openalex.org/A5067264823 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Yoshiaki Kamachi |
| authorships[13].countries | JP |
| authorships[13].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I96036126 |
| authorships[13].affiliations[1].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[13].affiliations[2].institution_ids | https://openalex.org/I4210091406 |
| authorships[13].affiliations[2].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[13].institutions[0].id | https://openalex.org/I96036126 |
| authorships[13].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[13].institutions[0].country_code | JP |
| authorships[13].institutions[0].display_name | Kumamoto University |
| authorships[13].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[13].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[13].institutions[1].country_code | JP |
| authorships[13].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Yoshiaki Kamachi |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[14].author.id | https://openalex.org/A5056281120 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Hiroyuki Tashiro |
| authorships[14].countries | JP |
| authorships[14].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I4210091406 |
| authorships[14].affiliations[1].raw_affiliation_string | Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 , |
| authorships[14].affiliations[2].institution_ids | https://openalex.org/I96036126 |
| authorships[14].affiliations[2].raw_affiliation_string | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5 |
| authorships[14].institutions[0].id | https://openalex.org/I96036126 |
| authorships[14].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[14].institutions[0].country_code | JP |
| authorships[14].institutions[0].display_name | Kumamoto University |
| authorships[14].institutions[1].id | https://openalex.org/I4210091406 |
| authorships[14].institutions[1].ror | https://ror.org/00bs3zm56 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I4210091406 |
| authorships[14].institutions[1].country_code | JP |
| authorships[14].institutions[1].display_name | Nagasaki Municipal Hospital |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Hiroyuki Tashiro |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Nagasaki Medical Association 4 , Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University 5, Nagasaki Pharmaceutical Association 1 , Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office 2 ,, Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division 3 , |
| authorships[15].author.id | https://openalex.org/A5020770218 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-6619-9310 |
| authorships[15].author.display_name | Harumi Yamada |
| authorships[15].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Harumi Yamada |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Nagasaki Prefectural Government Health & Welfare Department Pharmaceutical Administration Office |
| authorships[16].author.id | https://openalex.org/A5088032495 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Yoko Soh |
| authorships[16].affiliations[0].raw_affiliation_string | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Yoko Soh |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Nagasaki Prefectural Government Health & Welfare Department Medical Policy Division |
| authorships[17].author.id | https://openalex.org/A5003895966 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Kiyomi Hoshiko |
| authorships[17].countries | JP |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210118695 |
| authorships[17].affiliations[0].raw_affiliation_string | Nagasaki Medical Association |
| authorships[17].institutions[0].id | https://openalex.org/I4210118695 |
| authorships[17].institutions[0].ror | https://ror.org/02qv90y91 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210118695, https://openalex.org/I4210137409 |
| authorships[17].institutions[0].country_code | JP |
| authorships[17].institutions[0].display_name | Nagasaki Medical Center |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Kiyomi Hoshiko |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Nagasaki Medical Association |
| authorships[18].author.id | https://openalex.org/A5000897475 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-3064-1963 |
| authorships[18].author.display_name | Sumío Hirata |
| authorships[18].countries | JP |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I96036126 |
| authorships[18].affiliations[0].raw_affiliation_string | Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University |
| authorships[18].institutions[0].id | https://openalex.org/I96036126 |
| authorships[18].institutions[0].ror | https://ror.org/02cgss904 |
| authorships[18].institutions[0].type | education |
| authorships[18].institutions[0].lineage | https://openalex.org/I96036126 |
| authorships[18].institutions[0].country_code | JP |
| authorships[18].institutions[0].display_name | Kumamoto University |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sumio Hirata |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Center for Clinical Pharmaceutical Science and Division of Clinical Pharmacology Faculty of Pharmaceutical Sciences, Kumamoto University |
| authorships[19].author.id | https://openalex.org/A5038780663 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Choichiro Miyazaki |
| authorships[19].affiliations[0].raw_affiliation_string | Nagasaki Pharmaceutical Association |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Choichiro Miyazaki |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Nagasaki Pharmaceutical Association |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Community-Pharmacy based Trials for Drug Dose Adjustment in which Pharmacists Evaluate Renal Function |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13970 |
| primary_topic.field.id | https://openalex.org/fields/30 |
| primary_topic.field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| primary_topic.score | 0.9980000257492065 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3004 |
| primary_topic.subfield.display_name | Pharmacology |
| primary_topic.display_name | Pharmacy and Medical Practices |
| related_works | https://openalex.org/W2355255235, https://openalex.org/W2149214354, https://openalex.org/W2773909654, https://openalex.org/W2086707083, https://openalex.org/W1975027272, https://openalex.org/W2385829565, https://openalex.org/W239614157, https://openalex.org/W2325148501, https://openalex.org/W2388164371, https://openalex.org/W2586772472 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2020 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2018 |
| counts_by_year[3].cited_by_count | 2 |
| counts_by_year[4].year | 2017 |
| counts_by_year[4].cited_by_count | 1 |
| counts_by_year[5].year | 2016 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.5649/jjphcs.41.732 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764699316 |
| best_oa_location.source.issn | 1346-342X, 1882-1499 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1346-342X |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| best_oa_location.source.host_organization | https://openalex.org/P4327904648 |
| best_oa_location.source.host_organization_name | Japanese Society of Pharmaceutical Health Care and Sciences |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4327904648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| best_oa_location.landing_page_url | https://doi.org/10.5649/jjphcs.41.732 |
| primary_location.id | doi:10.5649/jjphcs.41.732 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764699316 |
| primary_location.source.issn | 1346-342X, 1882-1499 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1346-342X |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| primary_location.source.host_organization | https://openalex.org/P4327904648 |
| primary_location.source.host_organization_name | Japanese Society of Pharmaceutical Health Care and Sciences |
| primary_location.source.host_organization_lineage | https://openalex.org/P4327904648 |
| primary_location.license | |
| primary_location.pdf_url | https://www.jstage.jst.go.jp/article/jjphcs/41/10/41_732/_pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) |
| primary_location.landing_page_url | https://doi.org/10.5649/jjphcs.41.732 |
| publication_date | 2015-01-01 |
| publication_year | 2015 |
| referenced_works | https://openalex.org/W3168386511 |
| referenced_works_count | 1 |
| abstract_inverted_index./ | 80 |
| abstract_inverted_index.a | 54 |
| abstract_inverted_index.60 | 78 |
| abstract_inverted_index.In | 0, 57 |
| abstract_inverted_index.We | 34 |
| abstract_inverted_index.an | 27 |
| abstract_inverted_index.as | 13, 72, 165 |
| abstract_inverted_index.be | 138, 161 |
| abstract_inverted_index.in | 44, 96, 140 |
| abstract_inverted_index.is | 11, 32, 135, 158 |
| abstract_inverted_index.it | 60 |
| abstract_inverted_index.of | 30, 50, 65, 92, 102, 115, 132, 143, 171 |
| abstract_inverted_index.or | 21 |
| abstract_inverted_index.to | 88, 109, 127, 137, 160 |
| abstract_inverted_index.we | 86 |
| abstract_inverted_index.The | 100, 130 |
| abstract_inverted_index.and | 83, 113, 157 |
| abstract_inverted_index.for | 40, 104, 146, 168 |
| abstract_inverted_index.m2, | 82 |
| abstract_inverted_index.may | 24 |
| abstract_inverted_index.our | 58 |
| abstract_inverted_index.the | 51, 66, 90, 97, 141, 147, 162, 166 |
| abstract_inverted_index.was | 61, 76, 111, 119 |
| abstract_inverted_index.who | 153 |
| abstract_inverted_index.1.73 | 81 |
| abstract_inverted_index.dose | 9, 29, 42 |
| abstract_inverted_index.drug | 8, 22, 41 |
| abstract_inverted_index.eGFR | 75 |
| abstract_inverted_index.from | 107 |
| abstract_inverted_index.have | 68 |
| abstract_inverted_index.last | 163 |
| abstract_inverted_index.need | 87 |
| abstract_inverted_index.role | 131 |
| abstract_inverted_index.safe | 169 |
| abstract_inverted_index.that | 63, 85 |
| abstract_inverted_index.this | 122 |
| abstract_inverted_index.when | 26 |
| abstract_inverted_index.with | 2, 149 |
| abstract_inverted_index.3.3%, | 112 |
| abstract_inverted_index.50.3% | 64 |
| abstract_inverted_index.53.2% | 114 |
| abstract_inverted_index.acute | 18 |
| abstract_inverted_index.based | 38 |
| abstract_inverted_index.below | 77 |
| abstract_inverted_index.drugs | 145 |
| abstract_inverted_index.group | 59 |
| abstract_inverted_index.occur | 25 |
| abstract_inverted_index.ratio | 101 |
| abstract_inverted_index.renal | 48, 70, 94, 151 |
| abstract_inverted_index.their | 73, 93 |
| abstract_inverted_index.these | 116 |
| abstract_inverted_index.using | 53 |
| abstract_inverted_index.visit | 154 |
| abstract_inverted_index.which | 45 |
| abstract_inverted_index.work. | 99 |
| abstract_inverted_index.(CKD), | 6 |
| abstract_inverted_index.degree | 91 |
| abstract_inverted_index.drugs. | 172 |
| abstract_inverted_index.family | 133 |
| abstract_inverted_index.herein | 35 |
| abstract_inverted_index.injury | 20 |
| abstract_inverted_index.kidney | 4, 19 |
| abstract_inverted_index.mL/min | 79 |
| abstract_inverted_index.system | 124 |
| abstract_inverted_index.trials | 39 |
| abstract_inverted_index.adverse | 14 |
| abstract_inverted_index.average | 74 |
| abstract_inverted_index.bastion | 164 |
| abstract_inverted_index.chronic | 3 |
| abstract_inverted_index.confirm | 89 |
| abstract_inverted_index.disease | 5 |
| abstract_inverted_index.doctors | 110 |
| abstract_inverted_index.effects | 15 |
| abstract_inverted_index.hearing | 55 |
| abstract_inverted_index.inquiry | 103, 123 |
| abstract_inverted_index.survey. | 56 |
| abstract_inverted_index.cautious | 7 |
| abstract_inverted_index.clinics, | 156 |
| abstract_inverted_index.evaluate | 47 |
| abstract_inverted_index.expected | 159 |
| abstract_inverted_index.function | 49, 71, 152 |
| abstract_inverted_index.impaired | 69, 150 |
| abstract_inverted_index.inquired | 117 |
| abstract_inverted_index.medicine | 31, 106 |
| abstract_inverted_index.multiple | 155 |
| abstract_inverted_index.patients | 1, 52, 148 |
| abstract_inverted_index.required | 12 |
| abstract_inverted_index.revealed | 62 |
| abstract_inverted_index.important | 139 |
| abstract_inverted_index.including | 16 |
| abstract_inverted_index.inspector | 167 |
| abstract_inverted_index.performed | 36 |
| abstract_inverted_index.suggested | 84 |
| abstract_inverted_index.adjustment | 10, 43 |
| abstract_inverted_index.considered | 136 |
| abstract_inverted_index.dispensing | 98 |
| abstract_inverted_index.indicating | 121 |
| abstract_inverted_index.inspection | 142 |
| abstract_inverted_index.pharmacies | 134 |
| abstract_inverted_index.prescribed | 105, 144 |
| abstract_inverted_index.appropriate | 128 |
| abstract_inverted_index.contributed | 126 |
| abstract_inverted_index.medication. | 129 |
| abstract_inverted_index.outpatients | 67 |
| abstract_inverted_index.pharmacists | 46, 108 |
| abstract_inverted_index.potentially | 125 |
| abstract_inverted_index.readjusted, | 120 |
| abstract_inverted_index.drug-induced | 17 |
| abstract_inverted_index.intoxication | 23 |
| abstract_inverted_index.administered. | 33 |
| abstract_inverted_index.inappropriate | 28 |
| abstract_inverted_index.insufficiency | 95 |
| abstract_inverted_index.prescriptions | 118 |
| abstract_inverted_index.administration | 170 |
| abstract_inverted_index.family-pharmacy | 37 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 20 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8399999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.8479224 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |